The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the la-specific antibody APOMAB®

Alexander Staudacher, Fares Al-Ejeh, Cara Fraser, Jocelyn Darby, David Roder, Andrew Ruszkiewicz, Jim Manavis, Michael Brown

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)
    2 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the la-specific antibody APOMAB®'. Together they form a unique fingerprint.

    Medicine & Life Sciences